Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | W029541 | OT |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | OT |
no additional AE; HCP calling to report expired MMR-II administered on 03/17/25.; This spontaneous report was received from a medical assistant on 24-Apr-2025 and refers to a 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-Mar-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #W029541, expiration date: 15-Sep-2024), administered for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date not provided) (Expired product administered). The patient was not symptomatic. Unsupported outcome was delivered. Confirmed no temperature excursion (TE). No other information. No additional adverse event (no adverse event).